Email
Print
Market Overview:
The Human Milk Oligosaccharides Market size is estimated to reach $X Billion by 2030, growing at a CAGR of 21.9% during the forecast period 2024-2030, according to a recent report published by IndustryARC, titled, “ Human Milk Oligosaccharides Market - By Type (2’-Fucosyllactose (2’-FL), 3’-Fucosyllactose (3’-FL), 3'-Sialyllactose (3'-SL), 6'-Sialyllactose (6'-SL), Lacto-N-tetraose (LNT), Lacto-N-Neotetraose (LNnT) and Others), By Composition (Glucose, Galactose, N-Acetylglucosamine, Fucose and N-Acetylneuraminic Acid) By Nature (Acidic and Neutral), By Application (Infant Formula, Food Supplement, Functional Food & Beverages and Others) and By Geography - Opportunity Analysis & Industry Forecast, 2024-2030.
The rising demand for premium baby formula is driving the market, as parents increasingly seek high-quality, nutrition-rich products for their infants. Additionally, the growing popularity of gut health is fueling market growth, with consumers becoming more aware of the importance of infant digestive health and its role in overall well-being.
North America Dominated the Market in 2023:
In 2023, the North America region held the largest share in The Human Milk Oligosaccharides Market due to strong demand for infant nutrition solutions and increased investments in HMO research and production. This region benefits from progressive initiatives such as the Human Milk Banking Association of North America (HMBANA), which supports access to donor milk, and the U.S. Breastfeeding Committee's advocacy for inclusive feeding practices and broader access to human milk and formula alternatives. In recent years, various North American government agencies and organizations have collaborated on research to ensure the stability and growth of the infant formula market. For instance, in May 2023, the U.S. Food and Drug Administration (FDA) partnered with NASEM to conduct a study aimed at guiding the agency’s future long-term strategy for strengthening the U.S. infant formula supply. This strategy will focus on diversifying approaches to enhance the resilience of the formula supply chain, enhancing formula diversity and improving nutritional standards.
Human Milk Oligosaccharides Market: Key Takeaways
Rising Demand for Premium Baby Formula
The rising demand for premium baby formulas is significantly driving market growth. Parents are increasingly seeking high-quality, nutrient-rich alternatives that replicate breast milk's benefits. Premium formulas often include specialized ingredients like human milk oligosaccharides (HMOs), probiotics, and DHA, which enhance immune function, brain development, and digestive health. For example, in June 2023, Chr. Hansen's (now Novonesis) 6’-SL HMO mix was approved for use at the highest levels in infant and follow-on formula in the EU. Additionally, in November 2024, Abbott and Reckitt secured a win in an infant formula trial, further emphasizing the competitive and growing market. This trend is also fueled by the growing awareness of the long-term health benefits associated with these advanced formulas, leading to increased investment in research and product development by leading brands.
For More Queries About " Human Milk Oligosaccharides Market" @ https://www.industryarc.com/pdfdownload.php?id=800778
Growing Popularity of Gut Health
The growing popularity of gut health in early childhood development is significantly driving the market, being influenced by various factors, including birth delivery methods and natural surroundings. A study published in PLOS ONE in August 2023 revealed a link between gut microbiome diversity in infants and cognitive development. The findings suggested that outdoor exposure and a diverse environment contribute to shaping a healthier gut microbiome, which in turn may enhance cognitive abilities. As with an increasing focus on maintaining a healthy gut microbiome, products enriched with prebiotics, such as Human Milk Oligosaccharides (HMOs), are gaining attention. HMOs play a vital role in shaping the gut microbiota, supporting immune functions, and preventing harmful bacteria growth. This has led to the rise of infant formulas and functional foods specifically designed to promote digestive health and immunity, aligning with current consumer trends towards healthier, more natural nutrition solutions.
Scope of the Report:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recent Developments:
• In April 2024, Lallemand Health Solutions and DSM-Firmenich announced a collaboration to introduce new synbiotic solutions for early-life nutrition. The partnership focuses on synergistic formulations designed to support the healthy development of infants through scientifically-backed prebiotic and probiotic combinations.
• In January 2024, Food Standards Australia New Zealand (FSANZ) approved DSM-Firmenich's four human milk oligosaccharides (HMOs), including a mixture of 2’-fucosyllactose (2’-FL) and difucosyllactose (DFL), for use in infant formula products.
• In November 2023, Nestlé introduced its inaugural infant formula incorporating human milk oligosaccharides (HMOs) into the Chinese market, marketed under the Wyeth Illuma brand.
Human Milk Oligosaccharides Market: Competitive Landscape
BASF SE, DSM Firmenich , KYOWA HAKKO BIO CO. LTD., Inbiose N.V, Novonesis, zuChem, Inc., Elicityl SA, Nestlé S.A., Abbott, Royal FrieslandCampina N.V. and others.
Related Reports:
Galacto-Oligosaccharides Market- The Galacto-oligosaccharides market size is projected to reach $1.8 billion by 2027. Furthermore, it is poised to grow at a CAGR of 6.1% over the forecast period of 2022-2027. The general sentience for incorporating a healthy diet while managing basic aspects of nutrition along with regulatory nods from FDA and ESFA are some of the drivers for the Galacto-Oligosaccharides Industry.
2-Fucosyllactose Market- The 2-Fucosyllactose market size was estimated at $31.23 million in 2021, growing at a CAGR of 8.02% during the forecast period 2022-2027. The increasing awareness about the benefits of 2-Fucosyllactose and growing inclination towards food supplements in daily diet is set to further enhance the overall development of the 2-Fucosyllactose Market
Human Milk Fortifier Powder Market- Human Milk Fortifier Powder Market size is estimated to reach $121.3 million by 2027, growing at a CAGR of 13.4% during the forecast period 2022-2027. The heightened health awareness of parents pertaining to the well-being of their preterm babies who are born weak and with a weight less than 2000 grams is set to drive the Human Milk Fortifier Powder Market.
About IndustryARC™:
IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets.
IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format that assists an intelligent and informed decision-making process.
Contact Us:
Mr. Venkat Reddy
IndustryARC
Email: [email protected]
USA: (+1) 518-282-4727
Web: https://www.industryarc.com
Follow us on LinkedIn | Facebook | Twitter